NCT02142218

Brief Summary

The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2014

Longer than P75 for all trials

Geographic Reach
6 countries

80 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2014

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

September 29, 2016

Status Verified

September 1, 2016

Enrollment Period

3.9 years

First QC Date

May 16, 2014

Last Update Submit

September 28, 2016

Conditions

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ECOG Performance Status of 0-1
  • Histologically confirmed malignant melanoma
  • Progressed on or after treatment with an anti-CTLA4

You may not qualify if:

  • Active brain metastases
  • Life Expectancy \<6 weeks
  • Subjects who received prior therapy targeting T-cell costimulation or checkpoint pathways except for Anti CTLA-4 therapy
  • Subjects with autoimmune disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (80)

Local Institution

Mobile, Alabama, 36604, United States

Location

Southern Cancer Center Pc

Mobile, Alabama, 36608, United States

Location

Local Institution

Encinitas, California, 92024, United States

Location

Local Institution

Washington D.C., District of Columbia, 20057, United States

Location

Lynn Cancer Institute At Boca Raton Regional Hospital

Boca Raton, Florida, 33486, United States

Location

Cancer Specialists Of North Florida

Jacksonville, Florida, 32256, United States

Location

Mount Sinai Comprehensive Cancer Center

Miami Beach, Florida, 33140, United States

Location

Florida Hospital

Orlando, Florida, 32803, United States

Location

Winship Cancer Institute

Atlanta, Georgia, 30322, United States

Location

Summit Cancer Care

Savannah, Georgia, 31404, United States

Location

Oncology Specialists, S.C.

Park Ridge, Illinois, 60068, United States

Location

Oncology Hematology Associates Of Sw In

Newburgh, Indiana, 47630, United States

Location

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

Lutherville, Maryland, 21093, United States

Location

Nebraska Cancer Specialists

Omaha, Nebraska, 68130, United States

Location

Comprehensive Cancer Centers Of Nevada

Las Vegas, Nevada, 89148, United States

Location

North Shore Hematology/Oncology Associates, P.C.

East Setauket, New York, 11733, United States

Location

Icahn School Of Medicine At Mount Sinai

New York, New York, 10029, United States

Location

Mid Ohio Oncology/Hematology, Inc,Dba

Columbus, Ohio, 43219, United States

Location

Lehigh Valley Health Network

Allentown, Pennsylvania, 18103, United States

Location

St. Luke'S Hospital

Bethlehem, Pennsylvania, 18015, United States

Location

The Jones Clinic, Pc

Germantown, Tennessee, 38138, United States

Location

Tennessee Oncology, PLLC

Nashville, Tennessee, 37203, United States

Location

Waukesha Memorial Hospital

Waukesha, Wisconsin, 53188, United States

Location

Local Institution

Buenos Aires, Buenos Aires, 1019, Argentina

Location

Local Institution

Buenos Aires, Buenos Aires, 1431, Argentina

Location

Local Institution

Capital Federal, Buenos Aires, 1280, Argentina

Location

Local Institution

Ciudad Autonoma de Buenos Aire, Buenos Aires, 1181, Argentina

Location

Local Institution

Córdoba, Córdoba Province, 5000, Argentina

Location

Local Institution

Rosario, Santa Fe Province, S2000DSK, Argentina

Location

Local Institution

San Miguel de Tucumán, Tucumán Province, 4000, Argentina

Location

Local Institution

San Miguel de Tucumán, Tucumán Province, CPT4000IAK, Argentina

Location

Local Institution

Caba, 1426, Argentina

Location

Local Institution

Fortaleza, Ceará, 60130, Brazil

Location

Local Institution

Salvador, Estado de Bahia, 41950, Brazil

Location

Local Institution

Brasília, Federal District, 70200, Brazil

Location

Local Institution

Belo Horizonte, Minas Gerais, 30150, Brazil

Location

Local Institution

Belo Horizonte, Minas Gerais, 30380, Brazil

Location

Local Institution

Jd. Petropolis-Londrina, Paraná, 86015, Brazil

Location

Local Institution

Ijuí, Rio Grande do Sul, 98700, Brazil

Location

Local Institution

Passo Fundo, Rio Grande do Sul, 99010, Brazil

Location

Local Institution

Porto Alegre, Rio Grande do Sul, 90840, Brazil

Location

Local Institution

Florianópolis, Santa Catarina, 88015, Brazil

Location

Local Institution

Itajaí, Santa Catarina, 88301, Brazil

Location

Local Institution

Barretos, São Paulo, 14780, Brazil

Location

Local Institution

Jaú, São Paulo, 17210, Brazil

Location

Local Institution

Ribeirão Preto, São Paulo, 14025, Brazil

Location

Local Institution

Santo André, São Paulo, 09060, Brazil

Location

Local Institution

São José do Rio Preto, São Paulo, 15090, Brazil

Location

Local Institution

São Paulo, São Paulo, 01308, Brazil

Location

Local Institution

São Paulo, São Paulo, 01323, Brazil

Location

Local Institution

São Paulo, São Paulo, 01509, Brazil

Location

Local Institution

São Paulo, São Paulo, 03102, Brazil

Location

Local Institution

São Paulo, São Paulo, 04538, Brazil

Location

Local Institution

São Paulo, São Paulo, 05651, Brazil

Location

Local Institution

Calgary, Alberta, T2N 4N2, Canada

Location

Local Institution

Edmonton, Alberta, T6G 1Z2, Canada

Location

Local Institution

Kelowna, British Columbia, V1Y 5L3, Canada

Location

Local Institution

North Vancouver, British Columbia, V7L 2L7, Canada

Location

Local Institution

Vancouver, British Columbia, V5Z 4E6, Canada

Location

Local Institution

Winnipeg, Manitoba, R3E 0V9, Canada

Location

Local Institution

Moncton, New Brunswick, E1C 8X3, Canada

Location

Local Institution

St. John's, Newfoundland and Labrador, A1B 3V6, Canada

Location

Local Institution

Halifax, Nova Scotia, B3H 1V7, Canada

Location

Local Institution

Hamilton, Ontario, L8V 5C2, Canada

Location

Local Institution

London, Ontario, N6A 4L6, Canada

Location

Local Institution

Ottawa, Ontario, K1H 8L6, Canada

Location

Local Institution

Toronto, Ontario, M4N 3M5, Canada

Location

Local Institution

Toronto, Ontario, M5G 2M9, Canada

Location

Local Institution

Montreal, Quebec, H3T 1E2, Canada

Location

Local Institution

Québec, Quebec, G1R 2J6, Canada

Location

Local Institution

Saskatoon, Saskatchewan, S7N 4H4, Canada

Location

Local Institution

Bogotá, 110221, Colombia

Location

Local Institution

Bogotá, Colombia

Location

Local Institution

Cali, Colombia

Location

Local Institution

Medellín, MEDELLIN, Colombia

Location

Local Institution

Medellín, Colombia

Location

Local Institution

Lima, Lima Province, 34, Peru

Location

Local Institution

Lima, Lima Province, Peru

Location

Local Institution

Lima, 027, Peru

Location

Local Institution

Lima, Peru

Location

Related Links

MeSH Terms

Interventions

Nivolumab

Intervention Hierarchy (Ancestors)

Antibodies, Monoclonal, HumanizedAntibodies, MonoclonalAntibodiesImmunoglobulinsImmunoproteinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsSerum GlobulinsGlobulins

Study Officials

  • Bristol-Myers Squibb

    Bristol-Myers Squibb

    STUDY DIRECTOR

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2014

First Posted

May 20, 2014

Study Start

June 1, 2014

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

September 29, 2016

Record last verified: 2016-09

Locations